Janssen Joins MMRF Partners on Personalized Profiling Effort | GenomeWeb

NEW YORK (GenomeWeb News) – The pharmaceutical firm Janssen R&D has teamed up with the Multiple Myeloma Research Foundation to help MMRF and its partners pursue their Personalized Medicine Initiative, part of which is a large clinical and molecular profiling study.

MMRF said today that Janssen has joined its pre-competitive consortium, a group of partners that support the PMI and its Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile, or CoMMpass, program. The PCC partners provide both scientific and financial support for the initiative.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.